These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2840458)

  • 21. [Effect of antiatherosclerosis diet with different total caloric value on the level of high density lipoproteins cholesterol in patients with ischemic heart disease].
    Samsonov MA; Frolova IA; Paramonova EG; Zubenko AD; Sirota II
    Vopr Pitan; 1981; (5):15-20. PubMed ID: 7314609
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood lipids and lipoproteins in patients with ischemic heart disease without hyperlipoproteinemia].
    Tokarskaia ZB; Tel'nov VI
    Ter Arkh; 1982; 54(5):43-6. PubMed ID: 7101185
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of apoproteins A and B, lipoproteins and plasma lipids during treatment with bezafibrate in various forms of hyperlipoproteinemia].
    Saitta A; Bonaiuto M; Lanzafame F; Mileto A; Pernice F; Cinquegrani M; Mazza G; Micali G; Pangallo A; Fodale P
    Clin Ter; 1988 Mar; 124(5):373-81. PubMed ID: 2974348
    [No Abstract]   [Full Text] [Related]  

  • 25. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
    Lowry RP; Soltys G; Mangel R; Kwiterovitch P; Sniderman AD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2229-32. PubMed ID: 3547921
    [No Abstract]   [Full Text] [Related]  

  • 26. [Basal insulinemia, its relation to dyslipoproteinemias and arterial pressure].
    Suntsov IuI; Mazovetskiĭ AG; Zhukovskiĭ GS; Polesskiĭ VA; Zadoia AA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):33-7. PubMed ID: 7046764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertriglyceridemia associated with thrombocytopenia and lipoprotein lipase deficiency.
    Romics L
    Ann Intern Med; 1981 Nov; 95(5):660-1. PubMed ID: 7294572
    [No Abstract]   [Full Text] [Related]  

  • 29. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER; Sutherland WH; Temple Wa
    N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of low density and high density lipoprotein cholesterol by fat-modified diets. A survey of recent findings.
    Vessby B; Lithell H; Boberg J
    Hum Nutr Clin Nutr; 1982; 36(3):203-11. PubMed ID: 6749766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipoprotein lipase deficiency in 2 young patients (hyperlipoproteinemia type I)].
    Bakker HD; Abeling NG; Rammeloo JA; Jansen H; van Gennip AH
    Ned Tijdschr Geneeskd; 1985 Apr; 129(14):642-5. PubMed ID: 3990858
    [No Abstract]   [Full Text] [Related]  

  • 33. Corn bran supplementation of a low-fat controlled diet lowers serum lipids in men with hypercholesterolemia.
    Shane JM; Walker PM
    J Am Diet Assoc; 1995 Jan; 95(1):40-5. PubMed ID: 7798579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of procetofen on apolipoprotein A I and B concentrations in hyperlipoproteinemia.
    Viikari J; Solakivi-Jaakkola T; Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):362-5. PubMed ID: 6811447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
    Schiffl H; Weidmann P; Fragiacomo C; Noseda G; Bachmann C
    Schweiz Med Wochenschr; 1985 Jun; 115(26):907-11. PubMed ID: 3927481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dyslipidemia characteristics in arterial hypertension].
    Neverov IV; Baĭmatova DD
    Sov Med; 1984; (6):46-9. PubMed ID: 6379903
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical aspects of the problem of hyperlipoproteinemia and age].
    Reuter W
    Z Gesamte Inn Med; 1981 Mar; 36(5):141-5. PubMed ID: 7018098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperlipoproteinemia in necrotizing pancreatitis].
    Modzelewski B; Janiak A; Hołlyński J
    Pol Merkur Lekarski; 2005 Apr; 18(106):415-7. PubMed ID: 16161923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary type I hyperlipoproteinaemia--a metabolic and family study.
    Potter JM; Macdonald WB
    Aust N Z J Med; 1979 Dec; 9(6):688-93. PubMed ID: 294927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in serum lipid levels, lipid composition and lipoprotein fractions in patients with ischemic cardiopathies or arterial hypertension].
    Dakovska L; Orbetzov M; Orbetzova V; Yarovska N
    Paroi Arterielle; 1981; 7(1):15-22. PubMed ID: 7339537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.